Conference item : Abstract
The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
- Abstract:
- Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in patients with moderate-severe CKD.
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 28.0KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00198-018-4465-1
Authors
- Publisher:
- Springer London
- Host title:
- Osteoporosis International
- Journal:
- World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO IOF-ESCEO 2018) More from this journal
- Volume:
- 29
- Issue:
- S1
- Pages:
- S350-S351
- Publication date:
- 2018-07-27
- Acceptance date:
- 2018-02-21
- Event location:
- Krakow, Poland
- Event start date:
- 2018-04-19
- Event end date:
- 2018-04-22
- DOI:
- EISSN:
-
1433-2965
- ISSN:
-
0937-941X
- Subtype:
-
Abstract
- Pubs id:
-
pubs:827798
- UUID:
-
uuid:85eaed26-cad9-45e4-858e-2fef4a5f21ec
- Local pid:
-
pubs:827798
- Source identifiers:
-
827798
- Deposit date:
-
2018-03-05
Terms of use
- Copyright holder:
- International Osteoporosis Foundation and National Osteoporosis Foundation
- Copyright date:
- 2018
- Notes:
- This abstract was presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, 19-22 April 2018, Krakow, Poland.
If you are the owner of this record, you can report an update to it here: Report update to this record